Clinical trials
Rhinitis, Allergic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 19 |
| 2025 | 10 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Unknown status | 13 |
| Not yet recruiting | 12 |
| Recruiting | 12 |
| Terminated | 2 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Tongren Hospital | 7 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 6 |
| The First Affiliated Hospital with Nanjing Medical University | 4 |
| ALK-Abelló A/S | 3 |
| Anhui Palo Alto Pharmaceuticals, Inc. | 3 |
| Guangzhou Institute of Respiratory Disease | 3 |
| Keymed Biosciences Co.Ltd | 3 |
| Wecare Probiotics Co., Ltd. | 3 |
| Cheng Lei | 2 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhinitis, Allergic | 75 |
| Asthma | 11 |
| Rhinitis | 5 |
| Dermatitis, Atopic | 4 |
| Hypersensitivity | 3 |
| Rhinitis, Allergic, Perennial | 3 |
| Rhinitis, Allergic, Seasonal | 3 |
| Conjunctivitis, Allergic | 2 |
| Inflammation | 2 |
| Respiratory Tract Diseases | 2 |
Trials
Showing 26 to 50 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.